Publications by authors named "Thapi D Rao"

Claim this Profile
S
Structural basis for antibody recognition of the proximal MUC16 ectodomain.
Kwangkook Lee, Kay Perry, Mengyao Xu, Irva Veillard, Raj Kumar, Thapi Dharma Rao

J Ovarian Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents.
Thapi D Rao, Mengyao Xu, Stephanie Eng, Guangli Yang, Robin Manson

Mol Cancer Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition.
Oladapo O Yeku, Thapi Dharma Rao, Ian Laster, Artem Kononenko, Terence J Purdon

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation.
Brandon Nemieboka, Sai Kiran Sharma, Thapi Dharma Rao, Kimberly J Edwards, Su Yan

Nucl Med Biol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies.
Marina Stasenko, Evan Smith, Oladapo Yeku, Kay J Park, Ian Laster, Thapi Dharma Rao

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth.
Thapi Dharma Rao, Alberto Fernández-Tejada, Abram Axelrod, Nestor Rosales, Xiujun Yan

ACS Chem Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.
Thapi D Rao, Huasong Tian, Xun Ma, Xiujun Yan, Sahityasri Thapi

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agents.
Thapi D Rao, Nestor Rosales, David R Spriggs

Mol Cancer Ther· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen.
Alena A Chekmasova, Thapi D Rao, Yan Nikhamin, Kay J Park, Douglas A Levine

Clin Cancer Res· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis